Literature DB >> 34128597

Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.

Min Joo Choi1, Won Suk Choi2, Hye Seong3, Jun Yong Choi4, Jong Hyun Kim5, Yae Jean Kim6, Eun Young Cho7, Dong Hyun Kim8, Hyesook Park9, Heeyoung Lee10, Nam Joong Kim11, Joon Young Song3, Hee Jin Cheong3, Sang Il Kim12, Kyong Ran Peck13.   

Abstract

BACKGROUND: This study presents a framework for determining the allocation and distribution of the limited amount of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
METHODS: After analyzing the pandemic strategies of the major organizations and countries and with a literature review conducted by a core panel, a modified Delphi survey was administered to 13 experts in the fields of vaccination, infectious disease, and public health in the Republic of Korea. The following topics were discussed: 1) identifying the objectives of the vaccination strategy, 2) identifying allocation criteria, and 3) establishing a step-by-step vaccination framework and prioritization strategy based on the allocation criteria. Two rounds of surveys were conducted for each topic, with a structured questionnaire provided via e-mail in the first round. After analyzing the responses, a meeting with the experts was held to obtain consensus on how to prioritize the population groups.
RESULTS: The first objective of the vaccination strategy was maintenance of the integrity of the healthcare system and critical infrastructure, followed by reduction of morbidity and mortality and reduction of community transmission. In the initial phase, older adult residents in care homes, high-risk health and social care workers, and personal support workers who work in direct contact with coronavirus disease 2019 (COVID-19) patients would be prioritized. Expansion of vaccine supply would allow immunization of older adults not included in phase 1, followed by healthcare workers not previously included and individuals with comorbidities. Further widespread vaccine supply would ensure availability to the extended adult age groups (50-64 years old), critical workers outside the health sector, residents who cannot socially distance, and, eventually, the remaining populations.
CONCLUSION: This survey provides the much needed insight into the decision-making process for vaccine allocation at the national level. However, flexibility in adapting to strategies will be essential, as new information is constantly emerging.
© 2021 The Korean Academy of Medical Sciences.

Entities:  

Keywords:  COVID-19; Distribution; Korea; Policy; Survey; Vaccines

Year:  2021        PMID: 34128597     DOI: 10.3346/jkms.2021.36.e166

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  5 in total

1.  Impact of national Covid-19 vaccination Campaign, South Korea.

Authors:  Seonju Yi; Young June Choe; Do Sang Lim; Hye Roen Lee; Jia Kim; Yoo-Yeon Kim; Ryu Kyung Kim; Eun Jung Jang; Sangwon Lee; Eunjoo Park; Seung-Jin Kim; Young-Joon Park
Journal:  Vaccine       Date:  2022-05-08       Impact factor: 4.169

2.  SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household.

Authors:  Seonju Yi; Jong Mu Kim; Young June Choe; Sujin Hong; Siwon Choi; Seong Bae Ahn; Miya Kim; Young-Joon Park
Journal:  J Korean Med Sci       Date:  2022-01-03       Impact factor: 2.153

3.  Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents.

Authors:  Young June Choe; Seonju Yi; Insob Hwang; Jia Kim; Young-Joon Park; Eunhee Cho; Myoungyoun Jo; Hyunju Lee; Eun Hwa Choi
Journal:  Vaccine       Date:  2021-12-24       Impact factor: 3.641

4.  Short Term Impact of Coronavirus Disease 2019 Vaccination in Children in Korea.

Authors:  Hyunju Lee; Eun Hwa Choi; Young-Joon Park; Young June Choe
Journal:  J Korean Med Sci       Date:  2022-05-02       Impact factor: 5.354

5.  Age discrimination, the right to life, and COVID-19 vaccination in countries with limited resources.

Authors:  Peter Lloyd-Sherlock; Aravinda Guntupalli; Lucas Sempé
Journal:  J Soc Issues       Date:  2022-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.